Merck & Co., Inc. (MRK) financials
Healthcare · CIK 0000310158 · fiscal years FY2021–FY2025
In fiscal year 2025 (ending Dec 2025), Merck & Co., Inc. (MRK) reported $65.01B in revenue and $18.25B in net income, a net profit margin of 28.1%. Revenue changed +1.3% versus FY2024. Over FY2021–FY2025, revenue grew at a 7.5% compound annual rate. All figures are from Merck & Co., Inc.'s SEC 10-K filings.
Source: SEC EDGAR, CIK 0000310158. Data as of 2026-06-18.
Key ratios (FY2025)
| Metric | Value | Basis |
|---|---|---|
| Net profit margin | 28.1% | Net income ÷ revenue |
| Operating margin | — | Operating income ÷ revenue |
| R&D intensity | 24.3% | R&D expense ÷ revenue |
| Revenue YoY growth | +1.3% | vs FY2024 |
| Revenue CAGR (4y) | 7.5% | FY2021 → FY2025 |
Source: SEC EDGAR. Data as of 2026-06-18.
Annual financials by fiscal year
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $48.70B | $59.28B | $60.12B | $64.17B | $65.01B |
| Net income | $13.05B | $14.52B | $365.0M | $17.12B | $18.25B |
| Operating income | — | — | — | — | — |
| R&D expense | $12.24B | $13.55B | $30.53B | $17.94B | $15.79B |
| Total assets | $105.69B | $109.16B | $106.67B | $117.11B | $136.87B |
| Total liabilities | — | — | — | — | — |
| Shareholders' equity | $38.18B | $45.99B | $37.58B | $46.31B | $52.61B |
| Cash & equivalents | $8.10B | $12.69B | $6.84B | $13.24B | $14.56B |
| Diluted EPS | 5.14 | 5.71 | 0.14 | 6.74 | 7.28 |
| Revenue YoY growth | — | +21.7% | +1.4% | +6.7% | +1.3% |
Source: SEC EDGAR — Merck & Co., Inc. 10-K filings (CIK 0000310158). Data as of 2026-06-18. Revenue concept: Revenues.
How to read these figures
Revenue is the top line; operating income is profit from core operations before interest and tax; net income is the bottom line after every expense. The profit-margin calculator turns these into margins, and the revenue CAGR calculator annualises multi-year growth. For background, see revenue vs operating income vs net income and how to read a 10-K.
Frequently asked questions
What was Merck & Co., Inc.'s revenue in FY2025?
Merck & Co., Inc. reported $65.01B in revenue for fiscal year 2025 (period ending Dec 2025), per its SEC 10-K filing. That is +1.3% versus FY2024.
What is Merck & Co., Inc.'s net profit margin?
In FY2025, Merck & Co., Inc. earned $18.25B of net income on $65.01B of revenue — a net profit margin of 28.1%.
How fast has Merck & Co., Inc.'s revenue grown?
Between FY2021 and FY2025, Merck & Co., Inc.'s revenue grew at a compound annual rate (CAGR) of 7.5%.
Where does this Merck & Co., Inc. financial data come from?
All figures are taken from Merck & Co., Inc.'s annual 10-K filings on SEC EDGAR (CIK 0000310158), via the SEC XBRL company facts API. They are factual data, not investment advice — verify on SEC EDGAR before relying on them.
Source & verification
Figures are taken from Merck & Co., Inc.'s annual 10-K filings on SEC EDGAR (CIK 0000310158), via the EDGAR XBRL company facts API. They are factual data compiled from SEC filings — not investment advice; figures may contain errors or lag the original filing. Verify on SEC EDGAR before relying on them.
Last updated: 2026-06-18